Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 3/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | CDC25B | P30305 | 5/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.38 |
| ▸ | GJA1 | P17302 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13130031 | 0.94 | PTPN1 (0.45) | GJB2PTPN1SLC6A2CDC25BNT5E | |
| SCHEMBL15975418 | 0.93 | TP53 (0.45) | GJB2TP53MDM2 | |
| SCHEMBL16489969 | 0.88 | SLC6A2 (0.43) | SLC6A2LGALS8 | |
| SCHEMBL13130034 | 0.87 | POLB (0.44) | GJB2TP53MDM2 | |
| SCHEMBL13130030 | 0.82 | GJB2 (0.45) | GJB2PTPN1SLC6A2CDC25BNT5E | |
| SCHEMBL16489968 | 0.81 | SLC6A2 (0.44) | SLC6A2 | |
| SCHEMBL15975389 | 0.80 | GJB2 (0.48) | GJB2PTPN1SLC6A2CDC25BNT5E | |
| SCHEMBL15975421 | 0.80 | GJB2 (0.49) | GJB2PTPN1SLC6A2CDC25BNT5E | |
| SCHEMBL15975412 | 0.79 | MAG (0.43) | GJB2PTPN1SLC6A2CDC25BLGALS8 | |
| SCHEMBL15975401 | 0.79 | GJB2 (0.49) | GJB2PTPN1CDC25BNT5EPTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815239-B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | INSTITUT PASTEUR (FR) | 2014-08-26 | — | — | US | disclosed |